| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453585 | Lung Cancer | 2018 | 43 Pages |
Abstract
The establishment of genetically and clinically annotated NSCLC PDXs can yield a robust preclinical tool for biomarker, therapeutic target, and drug discovery.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Han Na Kang, Jae Woo Choi, Hyo Sup Shim, Jinna Kim, Dae Joon Kim, Chang Young Lee, Min Hee Hong, Seong Yong Park, A-Young Park, Eun Joo Shin, Seo Yoon Lee, Kyoung-Ho Pyo, Mi Ran Yun, Hun Mi Choi, Sung Sook Lee, Seok-Young Kim, Hanna Lee, Soonmyung Paik,